Washout Period of Xarelto (Rivaroxaban)
For rivaroxaban (Xarelto), stop 1 day before low-to-moderate bleeding risk procedures (skip 1 dose) and 2-3 days before high bleeding risk procedures (skip 2 doses) in patients with normal or mildly impaired renal function (CrCl ≥50 mL/min).
Preoperative Interruption Based on Bleeding Risk and Renal Function
The washout period for rivaroxaban depends critically on two factors: the bleeding risk of the planned procedure and the patient's renal function.
For Normal/Mild Renal Impairment (CrCl ≥50 mL/min):
- Low-to-moderate bleeding risk procedures: Stop rivaroxaban 1 day before the procedure (skip 1 dose) 1, 2
- High bleeding risk procedures: Stop rivaroxaban 2 days before the procedure (skip 2 doses) 1, 2
This approach is based on rivaroxaban's half-life of 8-9 hours 3. Stopping 1 day before allows approximately 2-3 half-lives to elapse (mild residual anticoagulant effect of 3-6%), while stopping 2 days before allows 4-5 half-lives (minimal residual effect of <6%) 3.
For Moderate Renal Impairment (CrCl 30-50 mL/min):
- Low bleeding risk: Stop 2 days before (skip 1 dose) 3
- High bleeding risk: Stop 3 days before (skip 2 doses) 3
For Severe Renal Impairment (CrCl 15-30 mL/min):
- Low bleeding risk: Stop 3 days before (skip 2 doses) 3
- High bleeding risk: Stop 4 days before (skip 3 doses) 3
Very High Bleeding Risk Procedures
For procedures with very high hemorrhagic risk (intracranial neurosurgery, neuraxial anesthesia/spinal puncture), extend the interruption period up to 5 days regardless of renal function 4. These procedures require near-complete absence of anticoagulant effect.
Key Clinical Considerations
No bridging therapy is needed with rivaroxaban due to its rapid offset and onset of action 1, 2. The 33% renal clearance of rivaroxaban makes renal function assessment essential before determining the washout period 3.
Common Pitfalls to Avoid:
- Don't use the same washout period for all patients: Renal function significantly affects rivaroxaban clearance and must be factored into timing
- Don't bridge with heparin: The rapid pharmacokinetics of rivaroxaban eliminate this need and bridging increases bleeding risk 2
- Don't forget to check recent creatinine: Use Cockcroft-Gault formula to calculate CrCl 4
- Consider drug interactions: P-glycoprotein inhibitors and CYP3A4 inhibitors can increase rivaroxaban levels, potentially requiring longer washout 4, 5
Postoperative Resumption
Resume rivaroxaban at least 24 hours after low-to-moderate bleeding risk procedures and 48-72 hours after high bleeding risk procedures, once hemostasis is established 3, 1. For major surgery, consider starting with a reduced dose (10 mg once daily) for the first 2-3 days before increasing to the full therapeutic dose 3.
The Canadian guidelines 6 recommend interruption begin 1-2 days before low bleeding risk procedures and 2-3 days before intermediate/high bleeding risk procedures, which aligns with the more recent 2022 CHEST guidelines 1 that provide the most current evidence-based approach.